Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
2.040
-0.010 (-0.49%)
At close: Apr 17, 2026, 4:00 PM EDT
2.050
+0.010 (0.49%)
After-hours: Apr 17, 2026, 7:59 PM EDT
Esperion Therapeutics Market Cap
Esperion Therapeutics has a market cap or net worth of $523.89 million as of April 17, 2026. Its market cap has increased by 90.51% in one year.
Market Cap
523.89M
Enterprise Value
904.04M
1-Year Change
90.51%
Ranking
Category
Stock Price
$2.04
Market Cap Chart
Since June 26, 2013, Esperion Therapeutics's market cap has increased from $204.10M to $523.89M, an increase of 156.68%. That is a compound annual growth rate of 7.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 523.90M | -40.77% |
| Dec 31, 2025 | 884.50M | 104.04% |
| Dec 31, 2024 | 433.50M | 27.50% |
| Dec 29, 2023 | 340.00M | -25.93% |
| Dec 30, 2022 | 459.00M | 215.68% |
| Dec 31, 2021 | 145.40M | -79.94% |
| Dec 31, 2020 | 724.80M | -55.52% |
| Dec 31, 2019 | 1.63B | 32.13% |
| Dec 31, 2018 | 1.23B | -28.50% |
| Dec 29, 2017 | 1.72B | 510.80% |
| Dec 30, 2016 | 282.40M | -43.67% |
| Dec 31, 2015 | 501.30M | -39.08% |
| Dec 31, 2014 | 822.90M | 290.00% |
| Dec 31, 2013 | 211.00M | 3.38% |
| Jun 26, 2013 | 204.10M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioAge Labs | 820.58M |
| Tilray Brands | 797.32M |
| Ironwood Pharmaceuticals | 722.35M |
| Eton Pharmaceuticals | 683.20M |
| Aquestive Therapeutics | 527.23M |
| Kamada | 486.21M |
| Emergent BioSolutions | 454.99M |
| Canopy Growth | 437.34M |